IRON
Disc Medicine, Inc.
NASDAQ · Healthcare · Biotechnology · US
$69.53
+0.51%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$1.65
- Revenue estimate
- $1.9M
Latest reported
- Last report date
- Jul 30, 2026
- EPS actual
- -$1.54
- EPS estimate
- -$1.71
- Revenue actual
- —
- Revenue estimate
- $1.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -4.4%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $102
- PT range
- $86 – $120
- Analysts
- 3
3 Buy0 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 30, 2026 | -$1.71 | -$1.54 | Beat 9.94% | — |
| May 5, 2026 | -$1.55 | -$1.65 | Miss -6.45% | — |
| Feb 26, 2026 | -$1.69 | -$1.71 | Miss -1.48% | -$19.9M |
| Nov 6, 2025 | -$1.48 | -$1.77 | Miss -19.59% | — |
| Aug 7, 2025 | -$1.17 | -$1.58 | Miss -35.04% | — |
| May 7, 2025 | -$0.99 | -$1.02 | Miss -3.03% | — |
| Feb 27, 2025 | -$1.06 | -$0.98 | Beat 7.55% | — |
| Aug 8, 2024 | -$1.11 | -$1.03 | Beat 7.21% | — |
| May 9, 2024 | -$1.00 | -$1.09 | Miss -9.00% | — |
| Mar 21, 2024 | -$0.75 | -$0.97 | Miss -29.33% | — |
| Nov 9, 2023 | -$0.75 | -$0.58 | Beat 22.67% | — |
| Aug 11, 2023 | -$0.88 | -$0.74 | Beat 15.91% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026